$2.04
0.010.49%
At close: -
$2.04
0.000.00%
After Hours: Jan 24, 6:56 PM EDT
Comments
Loading...
Sutro Biopharma (STRO) Forecast
NewsEarningsSutro Biopharma (STRO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSutro Biopharma (NASDAQ:STRO) Stock Quotes, Forecast and News Summary
Sutro Biopharma Stock (NASDAQ: STRO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sutro Biopharma (STRO) stock?
You can purchase shares of Sutro Biopharma (NASDAQ:STRO) through any online brokerage.
Who are Sutro Biopharma (STRO) competitors?
Other companies in Sutro Biopharma’s space includes: Renovaro (NASDAQ:RENB), Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE), Genfit (NASDAQ:GNFT) and Lexeo Therapeutics (NASDAQ:LXEO).
What is the forecast, or price target, for Sutro Biopharma (STRO) stock?
Sutro Biopharma has a consensus price target of $11.22.
What is the current price for Sutro Biopharma (STRO)?
The stock price for Sutro Biopharma (NASDAQ: STRO) is $2.04 last updated January 24, 2025 at 6:56 PM EST.
Does Sutro Biopharma (STRO) pay a dividend?
There are no upcoming dividends for Sutro Biopharma.
When is Sutro Biopharma (NASDAQ:STRO) reporting earnings?
Sutro Biopharma’s Q4 earnings are confirmed for Monday, March 24, 2025.
Is Sutro Biopharma (STRO) going to split?
There is no upcoming split for Sutro Biopharma.
What sector and industry does Sutro Biopharma (STRO) operate in?
Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.